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Abstract
SYSTEMATIC NURSING MANAGEMENT OF UNIVERSITY
STUDENTS WITH INFECTIOUS MONONUCLEOSIS
by
Lillian N. Yelton
Infectious Mononucleosis has been one of the most misdiagnosed
Its ability to mimic other diseases and the abun-entities in medicine.
dance of misconceptions about it have long confused both diagnosis and
Since there is still no specific drug to combat this disease.treatment.
patients with characteristic symptoms are treated symptomatically for the
period of extended convalescence. This study was carried out to explore
the possible effects of systematic nursing management on Infectious Mono­
nucleosis patients, in order to evaluate those things that significantly
influence the patient’s course of illness and recovery, in a university
outpatient health service.
The hypothesis formulated was: a patient with Infectious Mono­
nucleosis who receives systematic nursing management throughout the
course of his illness will, on the average, show a decreased length of
illness.
Random selection of twenty-four patients was made from those
students seeking, or who had sought, medical care for Infectious Mono­
nucleosis at the Student Health Service of California State University,
Fullerton, California. No tools of measurement were developed especially
for this study. The researcher extracted necessary information from the
The sample was divided into twomedical records, using a data sheet.
twelve patients who were seeking treatment (the experimentalgroups:
group), and twelve patients who had completed their treatment during the
previous academic year (the control group). To assure uniformity of
nursing care, the researcher provided a manual for systematic nursing
management to be followed by the nurses who cared for the experimental
group of patients.
Although not statistically significant, the data from the study
showed the findings to be in the predicted direction of the hypothesis.
Interesting trends were seen indicating that some patients in the experi­
mental group with Infectious Mononucleosis who received systematic nursing
management were, on the average, able to reduce the course of their clini­
cal symptomatology to two weeks less than that of the control group, even
though their atypical lymphocyte level was higher at the time of their
voluntary admission to treatment. The nurses caring for the experimental
group of patients through systematic nursing management increased their
Infectious Mononucleosis patient appointment load by 100 per cent, while
physicians treating the same group were able to reduce their Infectious
Mononucleosis patient appointment load by 31 per cent, thus freeing the
physicians to devote more time to other matters and patients who required
their special attention and clinical expertise.
Even though some limitations were placed on this study by its
small sample size and by the large variability manifested in the degree
of patients’ symptomatology, nursing implication from this study has been
significant in that the nurses caring for the experimental group of
patients, in their extended role with physician collaboration, were able
to render care comparable to that of the physicians who treated the con­
trol group of patients.
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INTRODUCTION
Since there is still no specific drug to combat Infectious
Mononucleosis, patients with the symptoms of this disease are treated
symptomatically. Though Infectious Mononucleosis has been in the medi­
cal literature for half a century, it is one of the most misdiagnosed
Its ability to mimic other disease and theentities in medicine.
abundance of misconceptions about it have long confused both diagnosis
and treatment.
The registered nurse is in a unique position to participate in
the surveillance and management of health care for university students
The nurse, an important member of thewith Infectious Mononucleosis.
health team in an ambulatory care setting, can work closely with her
patients to institute a systematic regimen of care in collaboration
with the physician.
Need for Study
There is little doubt about the importance of the nurse’s role
in the health improvement process of the patient with Infectious Mono­
nucleosis. However, to evaluate those things that significantly
influence the patient’s course of illness and to learn the relationship
between nursing management and patient recovery, analysis on an ongoing
basis in a variety of settings is needed.
The present growing concern for change in expanding the system
of health care has significant implications for nursing (Lysaught, 1970,
p. 81). Today, physicians and nurses are collaborating to achieve more
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effective understanding of the complementary functions of medicine and
nursing, and to formulate practical applications (Ardine and others,
1973, pp. 655-657; Keller, 1973, p. 73). The researcher has exper­
ienced the development of new collaborative relationships between nurses
and physicians in the University Health Center since the nurses assumed
certain expanded roles. Statistical data for the academic year of
1974-1975 for the Student Health Service of California State University,
Fullerton, California, showed 23,568 patient visits, 15,274 laboratory
procedures, and 1,508 radiological procedures. The health service phy­
sicians made 498 different medical diagnoses. Each new patient seeking
medical care was screened by the registered nurse functioning in the
expanded role with physician collaboration (Wickett, 1975, p. 1). Nurses
These bene-acting in the new role can bring many benefits to patients.
fits were observed by the investigator in connection with certain health
problems such as Infectious Mononucleosis.
Information is limited, in medical literature, about the dura­
tion of symptoms following acute infection and the nature of treatment.
The information available indicates disagreement as to treatment as well
as patient's symptomatology during the infection (Thompson and others.
1969, p. 453). Therefore, the medical clinician must rely upon the
patient's clinical condition and treat the patient symptomatically
(Miller, L. and others, 1972, p. 55).
Problem
It is important for nurses to identify, document, and account
for professional intervention in order to evaluate those things that
significantly influence the patient's course of illness.
3
The effectiveness of nursing intervention in the university
However, it has not beenhealth services can be seen in many ways.
In the case of Infectious Mononucleosis, due to the unique-documented .
ness of the disease, and the fact that no specific drugs have been found
to combat the disease, adherence to a regimen over a period of time is
important since the management of the patient by the nurses plays an
important role in the recovery (Tagliacozzo, 1974, p. 596).
Purpose of Study
The purpose of this study is to investigate nursing interven­
tions as they affect the patient’s course of illness and his rate of
recovery from Infectious Mononucleosis in a specific university health
service.
Hypothesis
A patient with Infectious Mononucleosis who receives systematic
nursing management throughout the course of his illness will, on the
average, show a decreased length of illness.
Definition of Terms
Systematic nursing management. A plan which concerns the regis­
tered nurse who is caring for the patients in an experimental group in
collaboration with physicians. She will be the only nurse responsible
for providing systematic nursing care for this patient. Under this
plan the nurse will, in cooperation with the patient, assess, plan.
implement and evaluate his health care. The plan includes:
Making the initial assessment, of the student’s status.a.
A
Observing, listening to, and evaluating the student's needs.b.
Interpreting laboratory tests for progress according to defined pro­
cedure.
Channeling students to the physician for a diagnostic work-c.
up and treatment.
Guiding the patient and taking the responsibility of teachingd.
and counseling him.
Planning and coordinating nursing care with other healthe.
care facilities.
Assuring continuity and equality of health care for thef.
duration of his illness.
Length of illness for this study was measuredLength of illness.
by the number of days from the time of voluntary admission into treatment
until the time the level of atypical lymphocytes was 20 percent.
Atypical lymphocytes. Lymphocytosis is characteristic of
Infectious Mononucleosis. Many patients show lymphocytosis with 20-90
percent concentration of atypical lymphocytes. White blood count
(W.B.C.), is usually elevated to about 15,000, although it may range
from 1,000 to 30,000. Atypical lymphocytes are larger than normal,
more darkly stained, and frequently will show vacuolization of nuclei
and cytoplasm (Miller and others, 1972, p. 44; Lyght, 1966, p. 759;
Valentine, 1963, p. 1157).
Voluntary admission into treatment. The day the patient enters
the student health center seeking help for his symptoms and the point
at which he is screened by the triage nurse.
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Triage nurse. The nurse who takes screening histories, physical
examinations, and orders appropriate laboratory tests to determine
priorities in the patient’s needs. This nurse also determines whether
or not the physician should see the patient immediately.
Infectious mononucleosis usually isInfectious mononucleosis.
an acute, self-limiting disorder with characteristic symptoms of fever.
pharyngitis, lymphadenopathy, splenomegaly, fatigue, lymphocytosis with
many atypical lymphocytes and may show the production of the heterophile
antibodies (Barnes, 1974, p. 35). The severity of this disorder is
determined by the virility of the innoculum (the virus), the host immune
All these factorsmechanism, and the degree of physical prostration.
must be considered together with laboratory findings and physical mani­
festations in order to determine the patient’s degree of illness (Morton,
1975). No specific therapy is available. Secondary bacterial invasion
should be sought and treated with appropriate antimicrobial drugs. Com­
plete recovery is almost certain, but splenic rupture can result in rapid
death unless treated surgically immediately. Neurologic complications
rarely occur (Valentine, 1963, p. 1159; Barnes, 1974, p. 35).
Assumptions
For purposes of this study, the following assumptions were made:
The nurse has the knowledge and skills needed to render1.
systematic nursing management to the patient with Infectious Mononucleo­
sis involving the physicians' collaboration.
The university student/patient has the education and ability2.
to comprehend the course of his illness. Thus, his participation in
6
health management planning will be an important factor in carrying ou.t
the regimen.
Physicians collaborate with nurses in patient care.3.
Limitations
The patient’s personal coping mechanism and the support1.
system at home will vary.
The nurse’s contact with her patient is limited because the2.
student health service is closed on week-ends and holidays.
The patient's clinical response to the personality of the3.
nurse will vary.
4. The selection of sample population for the experimental
group was restricted to the months of September through April.
5. The investigator has no control over the degree of the
patient’s illness and how long he has been ill before he sought medical
help.
REVIEW OF LITERATURE
The first account of Infectious Mononucleosis is generally
credited to Pfeiffer who, in 1889, described an epidemic in children
which he termed "glandular fever." Burns, in 1909, called attention
to an increase in mononuclear leukocytes in the blood. Sprunt and
Evans first applied the name Infectious Mononucleosis to the disorder
in 1920, and directed attention to the abnormally high content of leuko-
The leukocytes were described in detail in 1923 bycytes in the blood.
Downey and McKinlay (Valentine, 1963, p. 1157). Although Infectious
Mononucleosis has been in the medical literature for half a century.
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its etiology was not traced to Epstein-Barr Virus until late in 1968
by a husband and wife virologist team, Werner and Gertrude Henle.
However, it is a possibility that other nameless virus may have been
the cause of this disorder (Ginnis, 1968, p. 1; Hoagland, 1973, p. 98;
Miller, G. 1973, p. 229; Miller, L. , 1972, p. 44). In December of
1975, evidence of Cytomegalovirus Mononucleosis in adults was reported
(Bonkowsky and others, 1975, p.1284; Rosenthal, 1975, p. 1300).
Infectious Mononucleosis occurs largely in the 15 to 25 age
group, with an estimated incidence of 50 cases per 100,000 in the general
population (Barnes, 1974, p. 34). The prevalence of recurrence of this
Dr. Rose, of University of Nebraskadisorder is probably very rare.
Health Service, reported that after sixteen years’ experience with Infec­
tious Mononucleosis representing thousands of cases, he has not en­
countered a single recurrence. Incidentally, Dr. Rose usually did two
or three years of follow-up study to substantiate his findings (Rose,
1972, p. 195). The established facts are these: Infectious Mononucle­
osis is usually an acute, self-limiting illness of young adults and
It is identified by certain clinical hematologic and sero-children.
logic manifestations. Its characteristics are fever, malaise, pharyn­
gitis, lymphadenopathy, lymphocytosis with atypical changes in the
mononuclear elements of the peripheral blood, and production of the
heterophile antibody (Barnes, 1974, p. 34; Dirckx, 1972, p. 45;
Valentine, 1963, p. 1157). The symptomatic similarity of Mononucleosis
to other diseases leads to many misdiagnoses. It may resemble viral
or bacterial upper respiratory infections, the painful stiff neck of
meningitis, or the abdominal pains of either appendicitis or hepatitis
8
(Dirckx, 1972, p. 45; Hoagland, 1973, p. 99; Thompson, 1969, p. 453).
Wide publication of the association of Infectious Mononucleosis and the
Epstein-Bar Virus has not erased the popular belief that psychological
Dr. Johnfactors have something to do with the onset of the disease.
Miller, Director of Student Health at Indiana University, stated, "We
see more cases of Infectious Mononucleosis at times of stress, such as
midterms and finals, than at other times of the academic year" (Miller,
1972, p. 56). The contention that steroid therapy could provide sympto­
matic relief for the patients with Mono-Pharyngitis goes back to at least
1956, and the justification for the use of steroid therapy in treating
patients with Infectious Mononucleosis seems to be reasonably well
established in those cases in which fever is clinically manifested.
However, when the symptoms include a Pharyngotonsillitis (as occurs in
some 80 percent of the cases), the effectiveness of such steroid therapy
is subject to controversy (Klein, 1969, p. 446).
No specific therapy is available. Secondary bacterial invasion
with Streptococcal Pharyngitis, or Vincent’s angina, should be sought
and treated with appropriate antimicrobial drugs, 
ment of the fever and pharyngitis with salicylates and sedation for pain
Symptomatic treat-
is indicated when necessary. Splenic rupture occasionally occurs and
may be heralded by abdominal pain and shock. This complication calls
for prompt surgical intervention. Bed rest is recommended for severely
icteric patients and those with other forms of hepatitis. Adequate
rest and avoidance of activities in which splenic rupture may occur are
important in acute and convalescent periods. Fluid intake is important.
If a patient is too ill to swallow ice cream, Jello, or cold fluids.
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I.V. dextrose in saline or water may be administered in the hospital
(Barnes, 1974, p. 37; Lyght, 1966, p. 760; Miller, L. , 1972, p. 55;
Valentine, 1969, p. 1159). Other than occasional focal neurological
(See Appen-residuals reported, complete recovery is the general rule.
dix A for Mononucleosis pamphlet given to students with Infectious
Mononucleosis by the Student Health Service of California State Univer­
sity, Fullerton campus.) No reference was made as to dietary or nursing
management for the ambulatory patients in the literature.
The University health nurse clinician can be described as one
who shares major responsibility for assessing, planning, implementing.
and validating programs of nursing care, as well as teaching personnel
and participating in nursing research. She performs these functions
through individual actions, innovation, and collaboration with other
personnel involved in the care of the student. Nurses, in general, have
come a long way since nursing’s infancy which was marked by a close
paternal relationship with physicians and hospitals, when they were
taught, nurtured, fed, clothed and housed by hospitals employing them
(Dutton, 1969, p. 471; Marram and others, 1974, p. 7). However, sensi­
tive nurses have never limited their roles to the dictates of job
specifications and the status quo when human integrity demanded a
change in role. Nursing is contributing significantly to improving
health care by expanding its efforts to keep pace with changes in
health care delivery needs (Murata, 1975, p. 149). The appearance of
a report in 1971 of a committee convened by the Secretary of Health,
Education and Welfare, under the chairmanship of Dr. Roger Egeberg, to
study extended roles for nurses, made it very clear that nurses need.
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and want to be prepared for increased responsibility as members ofcan.
the health team (Pesch, 1972, p. 838). Today, physicians and nurses
collaborating to achieve more effective understanding of one anotherare
in order to redefine their complementary functions of medicine and nurs­
ing and to work out practical applications of new relationships (Arding
and others, 1973, pp. 655-657; Murray and others, 1975, p. 108). A com­
parison of available studies on expanded roles of nursing shows that the
nurse's influence can be studied in relation to diverse interests. These
studies are aimed at improving the patient's knowledge of illness, his
techniques of self-management and satisfaction with medical care. These
areas are key factors in compliance behavior of patients. The indica­
tions are that the trend is toward redistribution of responsibilities,
including a more active role for the nurse in an outpatient clinic, and
freeing the physician to devote more time to other specific matters.
Some studies deal with cost reduction in administration of health care
(Tagliacozzo, 1974, p. 596).
METHODOLOGY
The patient's comprehension of his problem and individual
psychological coping mechanisms are non-medical variables that affect
patient recovery. The search for clear factors influencing patient
recovery is compounded in the case of Infectious Mononucleosis because
there is still no specific treatment for this infection. The compara­
tive experimental method of study was chosen to control a factor (nurs­
ing care), in order to explore the possible relationships between
systematic nursing management and patient recovery.
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Variables
The independent variable in this study was the systematic nursing
management of the patient with Infectious Mononucleosis and the dependent
variable was the length of time, measured from the patient's entry into
treatment until the level of atypical lymphocytes in the blood reached
20 percent.
Setting
Student Health Service of California State University, Fullerton
campus, was the setting for this study. The student population at the
time the study was initiated was 21,809. This population is composed
entirely of off-campus residents and is a homogeneous mixture of all
ethnic and religious backgrounds.
Sample
The sample consisted of students of the California State Univer­
sity, Fullerton campus. However, not all students at the health service
were eligible to be in the study; only those who had an established
diagnosis of Infectious Mononucleosis were eligible. The sample con-
The first was a control group composed of 12sisted of two groups.
students selected from the medical records of those previously treated
for Infectious Mononucleosis at this University health service. They
were selected from the computer print-out of patients with this diagnosis.
starting with August, 1975, and going back as many months as necessary
to find 12 such patients. The second, or experimental group, was
selected from the students currently seeking diagnosis and treatment
As soon as each of their diagnoses wasfor Infectious Mononucleosis.
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All experimentalconfirmed, they were asked to be a part of the study.
(See Appendix Bsubjects gave written permission to be in the study.
for consent forms.) The physicians and nurses treating, or caring for.
the experimental students gave verbal consent to the investigator to be
Since the medical records and their confidentialitypart of the study.
were kept in accordance with the policies of the student health service.
the investigator did not obtain written consent specifically for this
study from the subjects of the control group. The written consent to
treat, given by these patients at the time they sought medical care.
was adequate in terms of record review.
The subjects for this study were selected according to the fol­
lowing criteria: (1) established diagnosis of Infectious Mononucleosis
based on a physical examination by the physician (criteria used to make
a diagnosis were determined by the individual physician), and by lab­
oratory data, and (2) the laboratory data must show the level of atypical
lymphocytes to be over 20 percent on the day of patient entry to treat­
ment .
The student health nurse, as an important member of the health
team in an ambulatory care setting, works closely with the patient and
in collaboration with the physician in order to institute a systematic
Because she is in a unique position to parti-regimen of health care.
cipate in the surveillance and management of health care for her
patients, she needs to question and investigate the relationships be­
tween nursing management and patient recovery instead of accepting ideas
and knowledge from authorities without question (Dutton, 1969, p. 42;
Notter, 1974, pp. 4-5). The registered nurses working in the student
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health service at the present time may or may not involve the patients
in the assessment planning, implementation and evaluation of their care.
Therefore, the nurses caring for the experimental group of patients were
given a manual of systematic nursing management to follow, in order to
facilitate adoption of the present system and standardize the nursing
(Seeintervention given to patients with Infectious Mononucleosis.
Appendix C for Systematic Nursing Manual.) A two-hour in-service educa­
tion class was conducted in order to present the use of the Systematic
Nursing Manual to the nurses.
The nurses volunteering to work with the experimental group
first triaged all possible cases, waited for confirmation of the diag­
nosis, then made a contract with the patients to care for those quali­
fying for the sample group.
Laboratory Procedure
Laboratory procedures were performed, according to the orders of
the physicians and nurses, by laboratory technologists employed by the
The data was then placed in the medical recordsstudent health service.
The procedures usually ordered to be performed were:of each patient.
C.B.C., or at times W.B.C. and differential with the level of atypical
lymphocytes, throat cultures and heterophile agglutination test.
All laboratory procedures carried out in the health service were
conducted according to current laboratory standards set and approved by
the State of California, assuring accuracy in laboratory reports.
Procedure for Collecting Data
The researcher extracted necessary information from student
14
(See Appendix D formedical records, using a prepared data sheet.
data sheet.)
Data Analysis
T-tests at the 5 percent level were performed on the means of
three principle factors associated with the patient's course of illness
(patients' course of illness measured in days, the length of time from
the day of diagnosis to the day the level of atypical lymphocytes
reached 20 percent, and the patients' start of treatment until the
atypical lymphocytes reached 20 percent, measured in days), to determine
whether there was a difference between the experimental and the control
group.
FINDINGS
A distribution of the sample, by age, is presented in Table 1.
No effort was made to control the number of students in the various
The range of ages for the control group (23-29) was small.categories.
while the ages of the experimental group (19-34) showed a wider spread.
The length of time which the medical personnel take to process
a patient from admission to diagnosis, or from diagnosis to treatment
should be fairly comparable from one year to another. Since the popu­
lation of the control group was selected from students from another
academic year, T-tests were done on both sample groups, in order to
examine any time differences that might have occurred.
Table 2 shows the results of the T-tests performed on the mean
number of days between triage and diagnosis, and the mean number of days
15
Table 1








between diagnosis and treatment. The results were not statistically
significant at the 5 percent level, which indicated that the two groups
of patients were processed in approximately the same length of time.
Therefore, both groups of patients from different academic years were
processed through the health service by the medical personnel at a com­
parable rate.
Table 2
Comparison of Health Service Processing of Patients 
in the Two Study Groups
p*Control ExperimentalMean Number of Days T
Number of days between 




2. Number of days between 
diagnosis and start of 
treatment 1.47 .16.5 1.5
* P is significant at the 5% level (a=.05)
Table 3 (control group) and Table 4 (experimental group) list
Table 3the secondary complications manifested by the sample groups.
However, be-shows few complications among the control group patients.
cause the pharyngeal cultures were omitted on four out of twelve of the
patients, the investigator was unable to come to an unbiased conclusion.
As a result of using systematic nursing management, the experimental
patients uniformly received pharyngeal cultures (Table 4). This group




Types of Pharyngeal Complications Manifested by Patients in 
the Control Group During the Course of Their Illness
Total of 12 Patients 
Listed by Patient Number 
as They Enter the Study
Type of Medication Prescribed
Antibiotics Steroids Others
1. No culture taken Yes No Yes
2. No culture taken Yes YesNo
Staph. Aureus Coag +3. Yes Yes Yes
4. Normal Flora Yes YesNo
Staph. Aureus Coag + many5. Yes No Yes
6. Staph. Aureus Coag + many Yes Yes Yes
7. Normal Flora No YesNo
No culture taken8. No No No
9.- Normal Flora Yes No No
10. No culture taken No No No
11. No Growth Yes No No
Staph. Aureus Coag +12. Yes No No
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Table 4
Types of Pharyngeal Complications Manifested by Patients in the 
Experimental Group During the Course of Their Illness
Total of 12 Patients 
Listed by Patient Number 
as They Entered the Study
Type of Medication Prescribed
Antibiotics Steroids Others
1. Staph. Aureus Coag. + 
heavy growth Yes No Yes
2. Hemoletic Staph. Aureus 
coag + heavy growth Yes Yes Yes
Hemoletic Staph. Aureus 
coag + heavy growth
3.
Yes No Yes




5. E- Coli. & Lactobacillus 
400 rg/ml Yes No Yes
6. Staph. Aureus Few Yes YesYes
Beta-Streptococcus, (Group A)7. Yes No No
Beta-Streptococcus, (Group A)8. Yes YesNo
9. Normal Flora No NoNo
10. Normal Flora Yes YesNo
Staph. Aureus coag +11. Yes Yes No
Beta-Streptococcus, (Group A)12. Yes NoNo
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Table 5 shows a comparison of the patients' course of illness
in terms of the mean number of days, the standard deviations and the
T-test values (cx=5%) . Although the differences were not significant
(a=.13), there was a 15-day difference between the two groups of patients
in favor of the experimental patients.
Table 5
Comparison of the Mean Number of Days, the Standard Deviations, 




45.1Mean Number of Days 30.4
Standard Deviation 29.5 10.2
T-Value P-Value
T-Test at 5% Level 1.62 .11
Table 6 compares the relationship between the level of atypical
lymphocytes (measured at the time of the patients' entry to the study).
and the length of the patients' course of illness. The mean level of
atypical lymphocytes and the mean number of days for the length of ill­
ness is also shown.
No correlation was seen between the levels of the patients'
atypical lymphocytes and the course of their illness. However, the
patients of the experimental group were able to reduce the average
course of their illness to 15 days less than that of the control group
patients.
Table 6
Comparison of the Relationship Between the Sample Population's Course of Illness and
Their Level of Atypical Lymphocytes
Control Group Experimental Group
Number of Days 
Between Triage 
and Atypical Lymph. 
Reaching 20%
Number of Days 
Between Triage 
and Atypical Lymph. 
Reaching 20%
Patient's Number as 





113 25%1. 30 70%
362. 50% 90%30
30%30%3. 17 39
4. 30% 65%20 39
50%95%565. 32
65%6. 80% 2425
85%7. 21 30% 13
448. 95% 65%36
9. 46 30% 32 80%
10. 18 4930% 99%
6411. 95% 27 90%
12. 81 80% 14 80%
Mean Level of 
Days 45 Atypical Lymph 55%
Mean Mean Level of 




Because not all patients began their treatment for Infectious
Mononucleosis on the same day as their diagnosis, the study presented
Table 7 shows a comparison between the two groupsin Table 7 was made.
of the difference in mean number of days from the start of treatment
until the day atypical lymphocytes reached 20 percent. Although a T-
test showed no significant difference in means (a=.14), there was a 14-
day difference between the two groups of patients, in favor of the
experimental group.
Table 7
A Measure of the Length of Time from the Day of Diagnosis 
to the Day the Level of Atypical Lymphocytes 
Reached 20 Percent
Control Experimental




Table 8 compares the mean number of days of illness of the con­
trol group and the experimental group, their respective standard
deviations in terms of the time from when diagnosis was confirmed to
the time the atypical lymphocytes reached the level of 20 percent. The
results of this comparison, while not significant (a=.ll) also showed a




Comparison of the Mean Number of Days, the Standard 
Deviations, and the T-Test Value at 5 Percent Level 
on the Patients' Start of Treatment Until the 
Atypical Lymphocytes Reached 20 Percent
ExperimentalControl
42.5Mean Number of Days 27.0
Standard Deviation 29.1 11.0
T-Value P-Value
T-Test (a=.05) 1.73 .11
Table 9 compares five other factors associated with measuring
the illness continuum. They were:
The number of days between start of treatment and end of1.
treatment.
The number of days from date of diagnosis until the atypical2.
lymphocytes were more than 20 percent.
The number of days from start of treatment until atypical3.
lymphocytes reached more than 20 percent.
4. The number of days from the time that the atypical lympho­
cytes were more than 20 percent to when they became less than 20 percent.
5. The number of days from the time the atypical lymphocytes
were less than 20 percent until the end of treatment.
T-tests were performed comparing the means of these five factors
for experimental and control groups. Although the differences between
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experimental and control groups were not statistically significant for 
any of the five factors (probably due to the small sample size), the 
experimental group of patients recovered, on the average, faster than
the control group.
Table 9
T-Tests Performed on Five Factors Associated With 
Measuring Illness Continuum of Patients
Experi­
mental P*Mean Number of Days Control T
Number of days between start 
of treatment and end of 
treatment .79 .4449 41
Number of days from date of 
diagnosis until atypical 
lymphocytes were more than 
20% .63 .541.5 2
Number of days from start of 
treatment until atypical 
lymphocytes were more than 
20% 1.09 .291.6 .66
Number of days between the 
time when atypical lympho­
cytes reached more than 
20% to when they became 
less than 20% 43 26 1.79 .09
Number of days from the time 
when atypical lymphocytes 
were less than 20% to end 
of treatment 4 1.43 .1715
* (a=.05)
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Table 10 shows a comparison of the two sample groups in common
physical manifestations of Infectious Mononucleosis.
Table 10
A Comparison of Common Physical Manifestations of the Two 
Sample Groups on the First Day of Triage
Frequency of Symptoms Shown 
by Number of Patients
Physical Manifestations Control Experimental
12Lymphadenopathy—Cervical 10
9 9Fatigue
Fever—over 99° F. 5 5
Pharyngitis—without exudate 5 3
Lymphadenopathy—Post Cervical Triangle 2 3
Tonsillitis—without exudate 2 2
Pharyngitis—with exudate 1 2
Tonsillitis—with exudate 1 5





Table 11 shows the number of patients treated for secondary
complications. The types of secondary complications manifested by the
patients were mostly pharyngeal (see Table 3, p. 17, and Table 4, p. 18,
for types of complications). Steroids were given when secondary compli­
cations added to the severity of the symptomatology and the discomfort of
the patient.
Table 11
Number of Patients Who Took Medication for Secondary 







Table 12 compares the difference in the amount of recording done
by the nurses caring for patients in the two groups. An absence of a
comment on a chart did not necessarily indicate that any particular step
in the treatment process was omitted. The nurses caring for the patients
in the experimental group generally followed the instructions in the
manual and charted most medical findings and nursing procedures. There
were a few instances when charting was not done in the experimental group.
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Table 12
Comparison of Charting by Nurses
Control Experimental
No No
Yes No Charting Yes No Charting
Nursing Assessment;
12 120 0 01. Physical assessment
2. Nutritional assessment
3. Social and environmental
assessment
4. Class workload assessment
0
12 02 0 10 0
1 0 11 11 0 1
21 110 10 0
Nursing Care Plan:
1. Make contract with patient
to be his nurse during 
course of illness
2. Set up nursing objectives
120 0 12 00
0 120 5 61
Patient Education:
111* 0 12 0 01. Mention:
2. Give pamphlet on
Mononucleosis
3. Advise viewing audiovisual
aids
4. Discuss lab tests
5. Discuss course of illness
6. Discuss rest and activity
7. Discuss medication
8. Notify professors
9. Notify family 
10. Notify employer
Diet, Nutrition
10 12 02 0 0
1* 11 12 00 0
1* 0 11 12 0 0
1* 0 11 12 00
1* 0 11 12 00
1* 0 11 012 0
40 120 5 3
6 31* 110 3
4 4 41* 0 11
Evaluation of Compliance to
Regimen:
1. Review patient's record
2. Record patient's compliance
with regimen
3. Record compliance of nurse
4. Record family compliance
1* 0 11 12 0 0
0 0 12 12 0 0
1* 0 11 10 0 2
1* 11 4 00 8
* This charting was the result of one nurse's input for one patient.
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Table 13 shows the number of times the nurses and the physicians
saw their patients by setting up an appointment to perform physical
Introduc-examinations, do counseling, or evaluate laboratory results.
tion of systematic nursing management to the nurses caring for the
experimental group of patients caused a significant reduction (pc.06) in
the number of appointments made for the physician treating the patients
with Infectious Mononucleosis. The change can be summarized by comparing
the mean number of appointments made by the two respective groups of
care givers. Nurses caring for the experimental, group of Infectious
Mononucleosis patients doubled their appointments, while the physicians
treating the same group of patients reduced their appointments for
Infectious Mononucleosis patients by 31 percent.
DISCUSSION
Findings of this study are not conclusive. This study showed
that six cases of Infectious Mononucleosis did occur in people over 27
years of age. Nurses must be careful, in considering all aspects of
patient screening,, before dismissing a patient as being too old to mani­
fest the symptoms of Infectious Mononucleosis.
Close examination of the data taken from this study shows that
the systematic nursing management guide (manual) was the major factor
in contributing to the uniformity of care given by the nurses to the
patients in the experimental group. For example, nurses following the
systematic nursing guide all took their patients' pharyngeal cultures
(Table 4). Ten out of twelve patients showed secondary complications
of the pharynx and were treated with appropriate drugs. On the other
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Table 13
Comparison of Nurse-Patient and Physician-Patient 




































* Difference for nurses was significant p<.01 
Difference for doctors showed p<.06
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hand, nurses caring for the patients in the control group were not
Four out of twelve patients did not havegiven a manual to follow.
their pharyngeal cultures taken, and two out of those patients received
antibiotic treatment for secondary complications which involved the
pharynx. Justifications for omitting the cultures were not recorded
(Table 3, p. 17).
Throughout the nurses' notes for the experimental group of
patients, the evidence of systematic nursing management was easily
detected. Precise charting was continued until the Infectious Mono­
nucleosis patients were discharged from care. Although this study did
not place its emphasis on nursing audit, the systematic nursing manual
provided a guide for uniform documentation which led to effortless,
successful auditing of the nursing records.
Although the experimental group manifested a higher level of
atypical lymphocytes than the control group at the beginning of their
treatment (Table 6, p. 20), these findings were not conclusive. How­
ever, a comparison of the mean number of days illness between those
patients in the experimental group and those patients in the control
group showed fifteen days difference in favor of the experimental group
(Table 5, p. 19). Comparison of Tables 12 and 13 showed data signifi­
cant to nursing performance. The nurses caring for the experimental
group of patients generally followed the instructions for systematic
nursing care and kept precise notations. The data showed through
systematic nursing care these nurses were able to increase their Infec­
tious Mononucleosis patient appointment load by 100 percent. At the
same time, physicians treating the experimental group of patients were
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able to reduce their Infectious Mononucleosis patient appointment load
by 31 percent, thus freeing the physicians to devote time to other
matters requiring their attention. The effect on the total nursing
workload was not evaluated.
It is possible that other variables were confounding the total
The small sample size together with the large variability inpicture.
the illness level of the patients could have contributed to a distor­
tion of the results. In a larger sampling using patients with a closer
illness level in the two groups the results might not follow those
found in this study.
CONCLUSION
The data from this study showed the findings to be in the pre­
dicted direction of the hypothesis that a patient with Infectious
Mononucleosis who receives systematic nursing management throughout the
course of his illness will, on the average, show a decreased length of
illness. Although limitations were placed on the research, nursing
implications were significant. The course of Infectious Mononucleosis
in the experimental group averaged 15 days less than those patients in
the control group. Nurse clinicians, working in a university health
environment with physician collaboration, did reduce the period of their
patients’ illness through systematic nursing management.
RECOMMENDATIONS FOR FURTHER STUDY
As a result of this study, the following recommendations are
made:
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Repeat the study, using a larger sample population.1.
Repeat this study on other California State University2.
campuses.
Do further studies, controlling variables such as age.3.
degree of illness at the beginning of the study, measure the relation­
ship between the factor of stress and Infectious Mononucleosis.
NURSING IMPLICATIONS
A nurse clinician working in a university student health service
with physician collaboration should design, implement, and evaluate a
system of nursing management (for patients with Infectious Mononucleosis)
in their ambulatory care setting. This type of systematic patient
management plan can be easily devised by nurse clinicians in a primary
care setting to be used with patients having other illnesses, such as
diabetes, hypertension, cystitis, etc.
Nursing audit can be enhanced by such a patient management plan.
The systematic nursing management manual not only provides criteria for
uniform patient care, but also establishes a reliable means with which
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QUESTIONS AND ANSWERS ON MONONUCLEOSIS
by
William H. Wickett, Jr., M.D. 
Medical Director, Student Health Center 
California State College, Fullerton
1. What Is Mononucleosis?
Infectious mononucleosis, usually known as "mononucleosis" or simply 
"mono," is an acute self-limited disease characterized by irregular 
fever, sore throat, swelling of the lymphatic glands, and having 
characteristic blood cell and blood serum changes. Although the 
disease was first described in 1889 as "glandular fever," it was not 
until 1920 that it was called "infectious mononucleosis." Greatest 
interest in mono dates from the first careful description of certain 
of the blood changes in 1932.
2. What Causes It? How Is It Spread?
It is believed that mono is infectious, but to date no causative agent 
has been found; however, some aspects of the disease make us suspect 
that a virus is involved. The disease is particularly common in 
young people of college age. It affects twice as many men as it does 
women. The mode of spread is thought to be by direct transmission of 
saliva such as by kissing or by sharing soft drink bottles. Trans­
mission through the air is possible, but roommates rarely catch it if 
one of them is sick with mono. It has been suggested, however, that 
some people may be carriers of mono. The incubation period for the 
sporadic type of mono is said to be between 4 and 7 weeks from contact 
to the first symptoms. There seems to be no particular seasonal inci­
dence.
3. What Are The Symptoms And Signs?
Most typically the onset of mono is vague, indefinite, and similar 
to the beginning of other infectious diseases. This first stage 
lasts 3 to 5 days. Next comes the active stage in which the patient 
may complain of any or all of the following symptoms: chills, sweats, 
fever, dizziness, sore throat, headache, aching behind the eyes, 
puffy eyelids, general body aching, fatigue, swollen neck glands, 
and inability to concentrate. Sometimes, however, the sore throat 
and enlarged neck glands are quite minimal, with presenting symptoms 
similar to influenza. The majority of "exposed" individuals do not 
become ill at all and may have the disease in such a mild form as to 
be quite unaware of its presence. Others may just feel "under par" 
for a period of time. The active stage of mono lasts from 7 to 21 
days in most cases.
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Is There Danger Of Complications?
The chance of complications is quite small. The liver is affected to 
some degree in all cases, so this is not considered a complication.
In occasional cases the liver is affected enough to produce jaundice. 
The luckily is not the same as infectious hepatitis. In almost all 
cases the liver involvement is unimportant and can be expected to 
disappear in a short time without permanent liver damage. Abnormal 
liver function tests are the expected finding and need cause no con­
cern.
4.
The spleen is usually enlarged somewhat, and occasionally it will 
become so enlarged that even moderate exertion or a blow to the abdo­
men may cause the spleen to rupture, resulting in severe internal 
hemorrhage. Significant enlargement of the spleen may be readily 
detected by the physician. Regular supervision by the physician is 
important even in mild cases.
The acute disease usually lasts from one to three weeks (occasionally 
four); and, as a rule, subsides without any problems.
There are no after-effects following the usual attack of mono. How­
ever, a generalized fatigue or "under par" feeling with mental 
depression and difficulty in concentration may occasionally be exper­
ienced for as long as three to six weeks. Recent research at the 
University of Colorado Student Health Center has shown that most 
patients who have prolonged periods of fatigue and depression fol­
lowing mononucleosis are likely to have basically depressive emotional 
patterns. Recurrences of mono after recovery are extremely rare; 
however, for a period of many months many acute virus infections may 
cause a return of fatigue, glandular swelling and some of the changes 
in the white blood cells similar to those of acute mono. Such cases 
do not represent active mono.
5. How Is It Best Diagnosed?
The diagnosis of mono is not difficult after the disease has fully 
developed; however, it may be exceedingly difficult to diagnose in 
some cases during the first few days after onset, since mono imitates 
many other acute diseases. The diagnosis is made on the basis of the 
(1) symptoms of fatigue, sore throat, etc.; (2) the physical signs 
of the mouth and throat, swollen lymph glands, enlarged spleen, etc.; 
(3) the finding of a larger than normal number of lymphocytes, of 
heterophile (sheep cells) test on the blood serum. Many other lab 
tests are needed from time to time to keep the doctor informed as to 
the state of his patient.
6. Is There Not Some Specific Cure For This Disease?
To date there is no specific cure—probably this is because the cause 
of mono may be viral in nature. The body builds up its own defenses 
and will overcome the disease in its own way. Antibiotics, such as 
penicillin, the "mycins," etc., have no effect on mono.
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When fever is present the first essential is bedrest, preferably in 
the hospital, until the temperature has been normal for a day or two. 
The patient should remain away from classes for a few days longer. 
Prolonged bedrest after the acute phase is over is practically never 
used, as it may actually prolong the recovery.
Such relapses seem to be more common when theRelapses do occur, 
patient returns to school too soon.
7. Must Most Students With Mono Withdraw Or Reduce Their Work Load?
No; however, some students, particularly those who are depressed, 
become discouraged and panicky and withdraw needlessly. Only a few 
find it necessary to drop out. Most are able to make the extra 
effort to make up their academic work.
Sports, particularly those involving vigorous exercise or body con­
tact, are prohibited even in mild cases until the doctor finds that 





The ailment for which you are seeking medical help has
The Studentbeen diagnosed as Infectious Mononucleosis.
Health Center at California State University, Fullerton, is 
participating in a study to evaluate the effect of systematic 
management of nursing care on patients diagnosed with Infec­
tious Mononucleosis.
You will be asked to make a decision involving your 
voluntary participation in this research program. Please 
take the time to read and evaluate the following information. 
It will help you to make an informed choice as to whether or 
not you wish to take part in this experimental research 
program.
Please feel free to direct any question you may have to 
the attending nurse or physician after you have read this 
information.
42
THE EFFECT OF SYSTEMATIC MANAGEMENT OF NURSING CARE 
ON PATIENTS DIAGNOSED WITH INFECTIOUS MONONUCLEOSIS 
AT CALIFORNIA STATE UNIVERSITY, FULLERTON 
STUDENT HEALTH CENTER
Infectious Mononucleosis is an acute self-limiting disease 
characterized by irregular fever, sore throat, swelling of the 
lymphatic glands, and having characteristic blood cell (atypi­
cal Downey cell) and blood serum changes. The cause was un­
known until about 1968 when the Epstein-Bar Virus was isolated. 
Although Infectious Mononucleosis can be found in children and 
occasionally in older people, most patients with this disease 
range from 15-25 years of age.
Due to its viral cause, there is still no specific drug 
to combat this disease and one must treat the patient sympto­
matically and rely upon his clinical condition. In contrast 
to the dramatic results of surgical intervention, the efforts 
of a nurse are less conspicuous, and are quite likely to be 
overlooked in the welter of activities that go on in most 
health care settings. Everyone knows that nurses are vital 
to the health process, but as yet the effect of nursing care 
has never been measured on patients diagnosed with Infectious 
Mononucleosis.
In order to evaluate total patient care, it is important 
for health professions to know if the nurse’s professional 
intervention for the patient with Infectious Mononucleosis 
can significantly reduce the time course of the illness, 
purpose of this study is to investigate nursing intervention 
as related to the effect on the patient's course of illness 
and on his rate of recovery from Infectious Mononucleosis.
The
If you choose to participate in this experimental research, 
the Registered Nurse assigned to the experimental group with 
physician collaboration will involve the patient in the assess­
ment, planning, implementation and evaluation of your nursing 
She will be the only nurse responsible for providingcare.
systematic nursing which will include:
Making the initial assessment of the student's health1.
status.
2. Observing, listening, and evaluating the student and 
his needs, interpreting laboratory tests for progress 
according to defined procedure.
3. Giving professional guidance and taking responsi­
bility for direction, including teaching and counseling.
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4. Channeling the student to the physician for diagnostic 
study and treatment.
5. Planning and coordination of nursing and other health
care.
Assure continuity of health care.6.
In short, the Registered Nurse assigned to you will guide 
and assist you in understanding your course of illness and your 
medical and nursing care in a systematic manner with physician 
collaboration.
Your confidentiality will be protected at all times and at 
no time will you be required to undergo laboratory tests that 
are not ordered or advised to take medications that are not pre­
scribed by the physician. You may withdraw your name at any 
time from this study if you wish for any reason. There will be 
no financial burden attached with this study.
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PATIENT CONSENT FORM
I, the undersigned, have read the information on the 
experimental research program being conducted at this center 
on the effect of systematic management of nursing care on 
patients diagnosed with Infectious Mononucleosis, 
stand:
I under-
That the purpose of the study is to investi­
gate nursing intervention as related to the effect 
on the patient's course of illness and on his rate 
of recovery from Infectious Mononucleosis.
That I will be asked to visit the Student 
Health Center regularly during the course of the 
study, and that I will be required to furnish blood 
specimens periodically for laboratory examination 
ordered by the physician.
That the medical record and its confiden­
tiality will be kept in accordance with the poli­
cies of the Student Health Center.
That I am free to withdraw from the study at 
any time, for any reason.
I hereby agree to volunteer as a subject in the program, 
and furthermore consent to allow the principal investigator, 
Lillian N. Yelton, R.N., or any of the physicians, nurses or 
assistants working under this program to assist me in my care 
of Infectious Mononucleosis.
Signed Date
Signature of Witness Date
o xiaNaddv
MANUAL
for Systematic Nursing Management
of
University Students with Infectious Mononucleosis
by




The chief purpose of introducting this systematic patient manage­
ment manual is to provide a guide to be used in caring for patients with
Infectious Mononucleosis during the research study.
This plan reflects all aspects of Infectious Mononucleosis care.
and involves a system of individualized patient care in collaboration
with the physicians.
The principal researcher is providing a vehicle that will allow
nurses to develop skills at the highest professional level, and at the
same time establish criteria for patient care evaluation.
The researcher’s grateful acknowledgement is extended to the
personnel of the Student Health Service, California State University,
Fullerton. Their valuable assistance, helpful suggestions, and concern
in developing this plan for systematic patient management are appreciated.




The following instructions are based on the nursing process.
This is the system by which the nurse identifies, plans, and implements
the nursing care of the patient. It is a problem-solving process which
can be defined in three steps: I. Assessment; II. Intervention; and
III. Evaluation.
I. Assessment Assessment is a complex phase in which data
concerning the patient are collected and sorted
into appropriate problem areas
Intervention consists of both planning andII. Intervention
giving care, with the patient’s problem in
Nursing objectives are formulated asmind.
statements of desired outcomes in patient
behavior as a result of nursing care
III. Evaluation ' Evaluation is the phase of the nursing process
in which the nurse uses measurable criteria to
learn whether or not the nursing objectives
were accomplished
CHARTING
The present system of problem oriented recording (including the
problem sheet), will be used to record all notations. This system has
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been effectively in use at the Student Health Service for over five years.
Therefore, there will be no further instructions on charting.
PROCEDURE
STEP I. PATIENT ASSESSMENT
The data base includes history, physical examinationA. DEFINITION.
and laboratory data. When the data base is accurate and complete.
the nurse has the opportunity to interpret the facts accumulated
and make a good problem list for her patient.
(See Part I of the Assess-B. THE COMPLETION OF PHYSICAL ASSESSMENT.
ment Form.)
The initial physical assessment by the nurse in the triage1.
will include:
Physical examination (problem oriented)a.
W.B.C. and Diff. (including the level of the atypicalb.
lymphocytes)
Pharyngeal culturec.
Problem oriented medical historyd.
C. THE COMPLETION OF A NUTRITIONAL ASSESSMENT. (See Part II of
Assessment Form.)
(SeeTHE COMPLETION OF A SOCIAL AND ENVIRONMENTAL ASSESSMENT.D.
Part III of Assessment Form.)
FORMULATE A PROBLEM LISTE.
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STEP II. IMPLEMENTATION OF THE NURSING CARE PLAN
A. DEFINITION. Planning the care of a patient is a multi-faceted
Once objectives for the care have been formulated byprocess.
careful review of the problem list, the next step is to contrive
various nursing approaches which might help achieve the goals.
Ideally, the selection of alternative approaches should be done
with patient collaboration. Your past experiences are helpful
resources for possible approaches, as well as indicators of the
plan's possible success. Nursing plans should show that the
nurse did consider the physical, mental, emotional, spiritual.
social, and environmental needs of patients. Nursing actions
should represent a variety of nursing measures: observing, com­
forting, counseling, teaching and referring.
As soon as the diagnosis of Infectious Mononucleosis is con-1.
firmed, make contract with the patient to be his nurse
during the course of his illness and until he is discharged
from care for this problem.
2. Explain to the patient about this Infectious Mononucleosis
research, and ask him to give consent to join the study.
The patient must sign a written consent form provided by the
researcher.
3. With physician collaboration, review physical findings,
medical history, and laboratory reports to plan course of
Involve the patient in all phases of healthtreatment.
care planning.
51
After completion of the medical and nursing plan, record4.
nursing objectives in the patient's medical record. Short
and long-term objectives should be written.
Laboratory procedures. After initial laboratory procedures5.
have been completed, in order to evaluate the patient's
course of illness, order the following laboratory tests:
W.B.C. and Diff., every week until the level of atypicala.
lymphocytes reaches 20 percent, and then P.R.N.
Repeat pharyngeal culture, if patient was placed on anti-b.
biotic therapy for secondary complications of pharyngitis.
(Repeat pharyngeal culture 10 days after the treatment.)
Other laboratory tests such as Sed. rate, Sgot., Sgpt.c.
should be done after consultation with the physician.
6. Arrange with your patient for a minimum of one appointment a
week to discuss the patient's problems, progress, care, and
evaluation (allowing time for patient education).
With patient's consent, notify his family, roommate, profes-7.
sors, and employers of his illness. If necessary, refer him
to other agencies.
8. Patient education by nurses should include the following:
Give the patient an Infectious Mononucleosis pamphleta.
and discuss it with him.
b. Explain the course of illness, the severity of the disease.
and warn the patient of the possible complications of
hepatitis and jaundice, splenomegaly, ruptured spleen.
hepatomegaly and others.
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Discuss laboratory tests and test results, explain toc.
the patient, in general, the names of the tests, the
reason for the tests, and the frequency of tests.
Advise the patient to view sound-over-slide (audio visual)d.
Infectious Mononucleosis information available in the
student Health Center and the Audio Visual Center on
Arrangements can be made through Dr. Wickett'scampus.
secretary.
Discuss diet and nutrition with the patient. Collaboratee.
with the physician as to the type, amount and frequency
(See attached dietof food to be eaten by the patient.
information sheet.)
Discuss medication regimen, if any, with the patient.f.
Review with the patient: when to take medication, dosage.
the rationale, and the signs and symptoms of undesirable
reactions and complications.
Discuss with patient rest and activities and other regi­g-
men associated with sleep.
STEP III. EVALUATION OF THE RESULTS OF NURSING MANAGEMENT
Evaluation is the phase of the nursing process inA. DEFINITION.
which the nurse uses measurable criteria to learn whether the
nursing objectives were accomplished.
CHECK LIST TO BE USED IN EVALUATING RESULTS OF SYSTEMATIC MANAGE-B.
MENT OF NURSING CARE:
1. Assessment




b. Nutrition assessment done?
Social and environmental 
assessment done?
c.
Class work load assessment done?d.
2. Nursing Care Plan
Contract made with patient to 





Diet and nutrition discussed?a.
b. Infectious Mononucleosis 
pamphlet given to patient?
Advice given to view Infec­
tious Mononucleosis sound- 
over-slide information?
c.
d. Laboratory test and test results 
discussed with patient?
The course of illness and pos­
sible complications discussed?
e.
f. Rest, sleep and activities 
discussed?







4. Evaluation of Compliance to Regime: Charting
Record review done by nurse?a.










(patient kept all appointments 
and adherence to regimen was 
documented.)
moderate____________
(patient missed two appointments 
and adherence to regimen was 
documented.)
poor
(patient missed three appointments 
and/or failed to adhere to regi- 
Document.)men.








(missed three of the required 
procedures)
poor
(missed five or more of the
required procedures)
5. Your recommendations for improvement 
of systematic patient management:
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ASSESSMENT FORM, PART I (PHYSICAL ASSESSMENT)
Complete the medical history (problem oriented) according to the1.
triage manual of the Student Health Center. Record findings.
Complete the physical examination (problem oriented) according to2.
the triage manual of the Student Health Center. Include the clinical
manifestations listed below which are typical of those manifested by






lymphadenopathy - post cervical triangle
lymphadenopathy - axilla
pharyngitis - s exudate
pharyngitis - c exudate
tonsillitis - s exudate













rash on body (morbilliform skin rash)
3. Send the patient to the laboratory for: W.B.C. and Diff. (need
report on the level of the atypical lymphocytes) and take a pharyn­
geal culture.
4. Refer patient to physician for diagnosis. The diagnosis of Infec-
rious Mononucleosis is confirmed by:
Physical examination (patient's clinical manifestations)a.
Laboratory tests (especially the level of the atypical lympho-b.
cytes). For the purpose of this study, the patient's level of
atypical lymphocytes at the time of triage must be at least 20%
to confirm the diagnosis.
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ASSESSMENT FORM, PART II (NUTRITIONAL ASSESSMENT)
Male and female dietary requirements are met by sound diet, based on
the Basic 4 food groups. Male and female caloric intake is based on
occupation, amount of physical activity or mental effort.several factors:
emotional state, age, body size, climate, and individual metabolism. It
is essential for the nurse to make accurate nutritional assessment of her






Money spent on food/weekWho prepares the food?



















ASSESSMENT FORM III (SOCIAL AND ENVIRONKENTAL ASSESSMENT)
Planning of patient care is dependent upon a body of information
about the patient, his family and his environment. This information
points out the need of the patient for nursing care and serves as a basis
for planning (L. Lewis, Planning Patient Care, p. 35.)
Show the Proper Classification
Apt.Housing: House Trailer Other
Marital Status: Married Not married
Other People (roommate)Living with: Family Alone
Miles traveled by student per day Other. By car Bus
Means of support: Parents Self Self and other
Does religious affiliation dictate style of living?
Other significant factors
Load of work: Total class units
Type of classwork very stressful? Yes No
If yes, reason
Physical activity—type, how much/day?
Sleep and rest habits—hours of sleep




Sit down type job?_____
Time of work— A.M.___
Other
P.M. Night Week-ends
Work environment: outside, exposed to weather?_____
inside but exposed to heat or cold
heated/air conditioned building___
well protected___
DIET INFORMATION FOR PATIENTS WITH INFECTIOUS MONONUCLEOSIS
Diet is flexible and may be adjusted 'to your individual eating habits. You should eat regularly, avoid 
all fried and highly seasoned foods such as pizza, sandwiches made from spicy lunch meats or greasy potato 
chips. Make sure some type of protein is included in each meal. Do not overeat at any meal.
FOODS TO OMITFOODS PERMITTED
Whole milk, nonfat milk, buttermilk, malted 
milk.
NoneMILK
Eggs may be fried inEggs fried in grease or oil. 
butter or vegetable oil.
Poached, scrambled, soft or hard boiled, 
baked, creamed, plain omelet or souffle.
EGGS
Any cheese with added spices or seeds.All cheeses except cheese with added 
spices or seeds.
CHEESE
Bologna, luncheon meats, sausage, frankfurters, ham 
and all salted and cured meats, except crisp bacon 
may be used. All fried meats, fish, and fowl.
MEATS Ground or tender beef, veal, lamb, fresh 
pork, liver, chicken, turkey. All meats 
should be broiled, boiled or roasted. 
Baked, broiled or steamed fish, such as 
cod, halibut, flounder, perch, haddock.
Raw cabbage, cauliflower, onions, broccoli, 
cucumbers, green peppers, radishes. Shredded 
lettuce may be used if tolerated.
Potatoes—mashed, boiled, or baked— 
do not eat the skin. Cooked or canned 
asparagus tips, green beans, beets, 
carrots, squash, canned peas, spinach, 
sweet potatoes, mushrooms, pumpkin, 
cabbage, cauliflower, onions, broccoli, 
tomatoes.
VEGETABLES
Canned or cooked peaches, pears, apple­
sauce, peeled apricots, baked apples 
without skins or seeds, royal anne cherries, 
ripe bananas, avocados. All fruit juices 





FOODS TO OMITFOODS PERMITTED
Highly seasoned soups. Read label for contents.Cream soups made with allowed vegetables 
permitted; broth, bouillon, consomme.
SOUPS
Rye bread, any bread with seeds. Any cereal con­
taining bran. Hot breads, rolls, pancakes (may be 
eaten in moderation).
BREAD & White and whole wheat bread. Refined 
CEREALS cooked cereals such as Cream of Wheat, 
Cream of Rice, Malto Meal, farina, oat­
meal. Puffed rice, puffed wheat, corn 
flakes. Crisp waffles. White rice, 
noodles, macaroni. Saltines, crackers 
without seeds, graham crackers, whole 
grain cereals.
All rich pies, pastries, candies, chocolate. Pies 
made with berries. Any dessert with coconut, seeds 
or nuts.
Jello, gelatine, custard, plaid puddings, 
ice cream, sherbet without seeds, plain 
cakes and cookies.
DESSERTS
Candy made with 
Pepper.
Preserves or jams with seeds, 
chocolate, coconut or nuts.
Jelly without seeds. Sugar, syrup, 




Highly seasoned gravy or spices. Seasoned salad 
dressings. Nuts, crunchy peanut butter.
Butter, oleo, mayonnaise, cream, crisp 
bacon, smooth peanut butter.
FATS
Regular coffee. Strong tea, cocoa. Alcoholic and 
carbonated beverages---- unless approved by physician.
BEVERAGES Any noncarbonated, nonalcoholic
beverage. Coffee substitutes. Decaf­
feinated coffee. Weak tea. Fruit 
juices without pulp. Tomato or citrus 
juices should be taken at the end of 





RESEARCH DATA COLLECTION 
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by
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not married2. marital status: married
3. birth year:
date of triage for this condition:4.
5. date of Dx:
6. date of treatment started:
date of treatment ended:7.
date of atypical lymphocytes over 20%8.
date of atypical lymphocytes less than 20%9.
% of atypical lymphocytes10. date of relapse if any:
date of recovery from relapse:11.
total length of treatment in weeks:12.
level of atypical lymphocytes:
atypical lymphocytes between 20-24%___
atypical lymphocytes between 25-49% 







Medical Diagnosis by Physician:
Name of Physician
not presentClinical Manifestations: present
14. fever
lymphadenopathy - cervical15.
lymphadenopathy - post cervical triangle16.
lymphadenopathy - axilla17.
- S exudate18. pharyngitis
- C exudatepharyngitis19.











rash on body (morbilliform skin rash)31.
Instruction by Physician: no
chartingPhysical activities yes no
Rest—Mention the importance of rest, 
increase sleep time, etc?
32.
If rest or sleep hours increased, how 






Diet-Food—Mention addition or deletion of 
food from diet? Give a diet to follow?
34.
35. If diet given what kind?
Medication
Medication given (Rx only)?36.





Contacts in behalf of student
Professor notified as to patient’s 
illness by health center personnel 
or by the patient?
41.
Patient’s family or extended family 
(roommate) notified by health center 
personnel or by the patient?
42.
Employer notified as to patient's 
illness by health center personnel 
or by the patient?
43.
Patient Education by Physician:
44. Infectious Mononucleosis pamphlet 
given to patient to read?
Advised to view sound-over-slide
information on Mononucleosis avail­
able in audio visual?
45.
Laboratory test and test results
explained to the patient in general 
(name of test, frequency, reason 
for testing, etc.)
46.
47. Discussion about Atypical Lymphocytes?




Discussion about other tests?49.
Explain the course of illness or discuss 







present semester units 
reduced semester units
51.
Occupation after class work?
If allowed to work after school 






Social and environmental assessment done?3.
4. Class work load assessment done?
Nursing Care Plan:
Make contract with patient to be his 





8. Infectious Mononucleosis pamphlet 
given to patient?
Advised to view sound-over-slide 
information available in audio 
visual?
9.
Laboratory test and test results 
discussed with patient?
10.
Discussed the course of illness and










Evaluation of Compliance to Regime:
Record review done by nurse?17.














Number of appointments made with the 
patient by the nurse/nurses______
22.
Number of appointments made with the 
patient by the physician/physicians
23.
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